- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis Access for Pain Treatment Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Policy Recommendations Pennsylvania
2020-21 Improvements and Recommendations
In June 2021 Governor Wolf authorized a continuation of the state’s COVID emergency measures through September. Just a week later, he signed HB 1024 which made curbside pickup a permanent fixture and allowed cannabis retailers to register employees as caregivers for the purposes of delivery. HB 1024 also included a measure to increase the amount of cannabis a patient can buy at a given time from 30 days to 90 days and a provision to provide financial assistance to low-income patients. Language that would’ve allowed for patients over 21 to grow up to five mature cannabis plants at home was unfortunately excluded from the final bill.
Pennsylvania saw a year of steady growth in patient enrollment. Since our last report, the state has gained over 46,000 new patients, a 15% increase. Pennsylvania is now one of five states with over 300,000 patients.
ASA recommends that the state focus their 2022 legislative efforts on expanding patient access, ensuring sufficient medical cannabis products are available, and working to reduce product costs. One strategy Pennsylvania should consider is to allow home cultivation of medical cannabis for able- bodied patients, which can dramatically reduce costs and ensure ongoing availability of medicine.
The state should also consider expanding the volume of licensed cultivators, manufacturers, testing laboratories and medical retail facilities to safeguard against supply shortages and improve patient access, as well as authorize delivery. Other program modifications to consider include organizing patient legal protections related to housing, as well as improving training requirements for facility staff. Finally, ASA recommends permanently maintaining the new access and telehealth enhancements under COVID, which greatly improve patient access and reduce patient cost burdens.